Recently, the 40th Brazilian Congress on Cardiac Arrhythmia 2024 was successfully held in Rio de Janeiro, Brazil. Shanghai MicroPort EP MedTech Co., Ltd. (referred to as "MicroPort EP") actively participated in the exhibition and set up an exclusive booth.

MicroPort EP showcased a range of innovative products in the field of electrophysiology, including the latest Columbus™ 3D EP Navigation System (referred to as "Columbus™ 3D System") and its compatible products, such as FireMagic™ TrueForce™ Ablation Catheter (referred to as "TrueForce™ Ablation Catheter"), EasyStars™ High Density Mapping Catheter (referred to as "EasyStars™ Catheter"), EasyFinder™ 3D Steerable Curve Diagnostic Catheter, EasyLoop™ 3D Circular Mapping Catheter, PathBuilder™ Transseptal Guiding Introducer, etc.

As a Chinese company providing a comprehensive EP solutions, MicroPort EP attracted over fifty experts from different countries including Brazil, Venezuela, Argentina, and Mexico to experience the performance of its products.

At the booth, three experts from Brazil showed strong interest in the entire product series, including the latest Columbus™ 3D System and its compatible products such as the TrueForce™ Ablation Catheter and EasyStars™ Catheter. After hands-on practice, they expressed that the catheter enables multi-electrode cardiac chamber modeling and high-density signal mapping, significantly reduced modeling time. The catheter demonstrated higher accuracy in identifying ECG signals.

Regarding the recently ANVISA-certified TrueForce™ Ablation Catheter, the experts expressed anticipation and highly praised its real-time prediction function for radiofrequency ablation lesion under force monitoring. The function is based on the quantified ablation index EI, assists in real-time assessment of ablation effects, providing operators with ablation guidance during procedures.

Two experts from Argentina, after fully experienced the Smart Label automatic acquisition feature of the latest version of the Columbus™ 3D System software, also expressed appreciation. They believed that the feature helps physicians objectively record ablation effects, avoiding subjective errors, and assists physicians in more accurately assessing treatment outcomes, thereby enhancing the safety and efficacy of the procedure.

For now, MicroPort EP's products have been exported to more than thirty countries and regions. In the future, MicroPort EP will actively expand its global reach, providing more comprehensive products and professional services to patients and physicians, offering a globally competitive integrated solution for electrophysiology intervention diagnosis and treatment.